Abivax Share Price
NASDAQ: ABVX | OthersAbivax Stock Performance
Abivax Share Price Today
As of 19 November 2026, Abivax SA's share price is $83.61. The stock opened at $82.96, compared to its previous close of $82.09. During today's trading session, Abivax SA's share price traded between $82.96 and $84.44, with an average price of $83.70. Over the past 52 weeks, the stock has recorded a high of $148.46 and a low of $69.91. In terms of performance, Abivax SA's share price has declined by 37.08% over the last six months and is down 33.09% on a year-on-year basis.
Abivax Share Price Chart
Abivax Annual Profit & Loss
All figures in USD
Abivax Balance Sheet
All figures in USD Million
Abivax Cash Flow
All figures in USD Million
About Abivax
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Abivax Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $87.17 | $83.61 | -3.49% |
Oct 2026 | $96.47 | $86.63 | -12.55% |
Sep 2026 | $112.36 | $99.06 | -13.40% |
Aug 2026 | $121.38 | $114.39 | -8.30% |
Jul 2026 | $137.75 | $124.74 | -6.41% |
Jun 2026 | $131.90 | $133.28 | +0.31% |
May 2026 | $117.50 | $132.87 | +13.25% |
Apr 2026 | $113.39 | $117.32 | +5.34% |
Mar 2026 | $117.66 | $111.38 | -8.18% |
Feb 2026 | $108.94 | $121.30 | +9.13% |
Jan 2026 | $136.56 | $111.15 | -17.62% |
Dec 2025 | $124.82 | $134.92 | +7.97% |